載入...
Cancer Drug Delivery: Considerations in the Rational Design of Nanosized Bioconjugates
[Image: see text] In order to efficiently deliver anticancer agents to tumors, biocompatible nanoparticles or bioconjugates, including antibody–drug conjugates (ADCs), have recently been designed, synthesized, and tested, some even in clinical trials. Controlled delivery can be enhanced by changing...
Na minha lista:
| 發表在: | Bioconjug Chem |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Chemical
Society
2014
|
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4275162/ https://ncbi.nlm.nih.gov/pubmed/25385142 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/bc500481x |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|